Our focus is where immunology research meets unmet medical need. Efgartigimod, a potentially first-in-class investigational antibody fragment is being studied across several autoimmune diseases and we’re exploring additional product candidates. Discover the breadth and depth of our pipeline.

Interested in Learning More?

Get argenx news and updates right to your inbox


Download assets
Get photos, fact sheets, illustrations and more.
Join the team
Dare to do more with a thriving career at Argenx.
Follow us
Get the latest news and info via our social media channels.